Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.21888 | 69 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.09074 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.32984 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.46619 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.20002 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.28199 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.06085 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.24275 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.08887 | 67 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.07407 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.14449 | 68 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.73862 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.18362 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.14689 | 68 |